CD8A and neoplasm: Despite KVK heterologous prime-boost inducing significant tumor remission in both E.G7-OVA and TC-1 tumor models, tumors were able to relapse at later time points, despite the presence of high levels of circulating antigen-specific CD8+ T cells.